Income Statement Presentation 2023

2022: Core operating profit and margin 43.7% 41.2% 42.1% % of sales 36.9% 34.9% 35.0% +1.3%p¹ +0.4%p¹ 22.1% 18.6% 20.1% +3%¹ CHFM 21,536 21,897 22,173 +5%¹ -1.7%p¹ 19,477 18,548 19,172 2020 2021 2022 Roche Group Pharma Division At CER-Constant Exchange Rates -5%¹ 2,564 3,925 3,556 Roche Diagnostics Division 55

View entire presentation